NCT05620888 Efficacy of a Tailored Communication Intervention Aimed At Increasing the Number of Daily Steps
| NCT ID | NCT05620888 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Milano Bicocca |
| Condition | Physical Inactivity |
| Study Type | INTERVENTIONAL |
| Enrollment | 255 participants |
| Start Date | 2022-10-03 |
| Primary Completion | 2024-09-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 255 participants in total. It began in 2022-10-03 with a primary completion date of 2024-09-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to evaluate the efficacy of a physical activity promotion intervention focused on walking behavior. The intervention is delivered via mobile application in a sample drawn from the healthy adult population.
Eligibility Criteria
Inclusion Criteria: * Participants from the general population, in good health and sedentary * A level of education sufficient to understand the procedures of the study and to use a smartphone * Having a smartphone Exclusion Criteria: * The participant always (or almost always) takes at least 7,000 steps a day * The participant achieves an IPAQ score equal to or greater than 3000 MET-min / week * The participant has symptoms or pathologies that could represent a contraindication to the physical activity proposed by the study. In particular * Cardiovascular diseases for which physical activity is allowed only under medical supervision * Chest pain during daily activities * Drug treatment for cardiovascular diseases * Severe arterial hypertension not pharmacologically controlled * Episodes of loss of consciousness within the past 12 months * Osteoarticular disorders that could be aggravated by a change in the level of physical activity * Fractures of the lower limbs, vertebrae, or pelvis in the past six months * Walking difficulty * Respiratory insufficiency
Contact & Investigator
Marco D'Addario, PhD
PRINCIPAL INVESTIGATOR
University of Milano Bicocca
Frequently Asked Questions
Who can join the NCT05620888 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 70 Years, studying Physical Inactivity. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05620888 currently recruiting?
Yes, NCT05620888 is actively recruiting participants. Contact the research team at marco.daddario@unimib.it for enrollment information.
Where is the NCT05620888 trial being conducted?
This trial is being conducted at Milan, Italy.
Who is sponsoring the NCT05620888 clinical trial?
NCT05620888 is sponsored by University of Milano Bicocca. The principal investigator is Marco D'Addario, PhD at University of Milano Bicocca. The trial plans to enroll 255 participants.